Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Cardiff Oncology, Inc. (CRDF)
USD0.89
-0.42 (-32.11%)
US NASDAQ Healthcare Biotechnology
Address
11055 Flintkote Avenue 92121
San Diego, CA, US
San Diego, CA, US
CEO
Mani Mohindru
Website
cardiffoncology.com
IPO
2004-07-27
CIK 1213037 ISIN US14147L1089
Description
Cardiff Oncology, Inc., a clinical-stage biotechnology company, develops novel therapies for the treatment of various cancers in the United States. Its lead drug candidate is Onvansertib, an oral and selective polo-like kinase 1 inhibitor for treating RAS-mutated metastatic colorectal cancer. The company also focuses on the clinical program in indications, such as investigator-initiated trials in metastatic pancreatic ductal adenocarcinoma, small cell lung cancer, metastatic triple negative breast cancer, and chronic myelomonocytic leukemia; CRDF-004, a Phase 2 open-label randomized multi-center clinical trial of onvansertib in combination with FOLFIRI and bevacizumab or FOLFOX and bevacizumab for the treatment of patients confirmed metastatic and unresectable colorectal cancer in patients with a KRAS or NRAS mutation; and TROV-054, a Phase 1b/2 single-arm clinical trial in KRAS-mutated metastatic colorectal cancer. The company was formerly known as Trovagene, Inc. and changed its name to Cardiff Oncology, Inc. in May 2012. Cardiff Oncology, Inc. was founded in 1999 and is headquartered in San Diego, California.
Market Cap & Enterprise Value
Merger & Acquisition History
No mergers or acquisitions recorded for this company.
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
USD0.89
-0.42 (-32.11%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
1M
Beta
1.38
Float Shares
66.71M
Free Float %
97.6%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +2.37% | +7.45% | +6.13% | +8.13% | -18.78% | -38.43% | -35.21% | -1.14% | -79.77% | -99.44% | -99.89% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Analyst Consensus (12 ratings, all time)
Buy
Price Targets & DCF
Current price
0.89
DCF (Unlevered)
0.01
-98.8%
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
Ratings Trend (MoM)
88% Bullish
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 1 | 0 |
| Buy | 6 | 0 |
| Hold | 1 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
Quality scores
Altman Z-Score
-9.97
Distress
Piotroski F-Score
1 / 9
Weak
MOAT Score
0 / 10
No MOAT
Composite Rating
C-
Overall Score
1 / 5
Low
DCF Score
1 / 5
Low
ROE Score
1 / 5
Low
ROA Score
1 / 5
Low
D/E Score
3 / 5
Medium
P/E Score
1 / 5
Low
P/Book Score
2 / 5
Medium
Operational MOAT
✗ Below peers
-
Revenue growth Biotechnology: +1.6%-13.2% Q1'26: -100.0% (vs Q1'25)
-
EPS growth Biotechnology: +29.7%+27.4% Q1'26: +35.7% (vs Q1'25)
-
FCF margin FCF growth · Biotechnology: +16.2%-7,223.8%
-
EBIT margin Biotechnology: +0.0%-7,736.3%
-
ROIC Biotechnology: -16.1%— Q1'26: +0.0% (vs Q1'25)
-
Share dilution Biotechnology: -3.4%+40.3% Q1'26: +43.4% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Biotechnology: 0.16×-0.02× Q1'26: -0.01× (vs Q1'25)
Valuation Multiples
From
To
Price Forecast (3Y)
From
To
Theoretical Return — If Invested Today
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
Consensus Estimates
| Metric |
Dec 2015 actual |
Dec 2016 actual |
Dec 2017 actual |
Dec 2018 actual |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 7 Rev. Ana. 6 EPS Ana. |
Dec 2027 5 Rev. Ana. 5 EPS Ana. |
Dec 2028 5 Rev. Ana. 5 EPS Ana. |
Dec 2029 2 Rev. Ana. 1 EPS Ana. |
Dec 2030 2 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
313.0K
est: 337.6K (-7.3%)
|
381.0K
est: 854.7K (-55.4%)
|
505.0K
est: 369.8K (+36.6%)
|
378.0K
est: 590.0K (-35.9%)
|
244.6K
est: 378.5K (-35.4%)
|
366.0K
est: 267.5K (+36.8%)
|
359.0K
est: 218.2K (+64.6%)
|
386.0K
est: 277.3K (+39.2%)
|
488.0K
est: 665.0K (-26.6%)
|
683.0K
est: 624.5K (+9.4%)
|
593.0K
est: 455.0K (+30.3%)
|
337.8K
244.6K – 401.8K
-25.8% YoY
|
287.5K
174.6K – 374.8K
-14.9% YoY
|
100.0K
66.7K – 124.6K
-65.2% YoY
|
101.51M
67.67M – 126.44M
+101,407.5% YoY
|
308.41M
205.61M – 384.16M
+203.8% YoY
|
| EBITDA |
-24.89M
est: -337.6K (-7,274.1%)
|
-36.76M
est: -854.7K (-4,200.9%)
|
-22.82M
est: -21.75M (-4.9%)
|
-15.70M
est: -590.0K (-2,561.0%)
|
-15.92M
est: -15.35M (-3.7%)
|
-18.84M
est: -267.5K (-6,942.6%)
|
-28.40M
est: -24.00M (-18.4%)
|
-39.67M
est: -35.38M (-12.1%)
|
-45.01M
est: -665.0K (-6,669.0%)
|
-48.25M
est: -624.5K (-7,625.7%)
|
-44.97M
est: -455.0K (-9,784.0%)
|
-337.8K
-401.8K – -244.6K
+25.8% YoY
|
-287.5K
-374.8K – -174.6K
+14.9% YoY
|
-100.0K
-124.6K – -66.7K
+65.2% YoY
|
-101.51M
-126.44M – -67.67M
-101,407.5% YoY
|
-308.41M
-384.16M – -205.61M
-203.8% YoY
|
| EBIT |
-25.27M
est: -337.6K (-7,386.3%)
|
-37.53M
est: -854.7K (-4,291.1%)
|
-23.87M
est: -24.38M (+2.1%)
|
-16.44M
est: -590.0K (-2,685.7%)
|
-16.41M
est: -16.11M (-1.9%)
|
-19.31M
est: -267.5K (-7,116.8%)
|
-28.86M
est: -24.94M (-15.7%)
|
-39.90M
est: -36.60M (-9.0%)
|
-45.41M
est: -665.0K (-6,728.9%)
|
-48.65M
est: -624.5K (-7,690.4%)
|
-45.88M
est: -455.0K (-9,982.6%)
|
-337.8K
-401.8K – -244.6K
+25.8% YoY
|
-287.5K
-374.8K – -174.6K
+14.9% YoY
|
-100.0K
-124.6K – -66.7K
+65.2% YoY
|
-101.51M
-126.44M – -67.67M
-101,407.5% YoY
|
-308.41M
-384.16M – -205.61M
-203.8% YoY
|
| Net Income |
-27.47M
est: -3.60B (+99.2%)
|
-39.20M
est: -4.56B (+99.1%)
|
-24.91M
est: -23.05M (-8.1%)
|
-16.46M
est: -385.97M (+95.7%)
|
-16.41M
est: -15.87M (-3.4%)
|
-19.31M
est: -48.96M (+60.6%)
|
-28.29M
est: -24.40M (-15.9%)
|
-38.70M
est: -36.37M (-6.4%)
|
-41.44M
est: -40.88M (-1.4%)
|
-45.43M
est: -65.38M (+30.5%)
|
-45.88M
est: -51.33M (+10.6%)
|
-43.70M
-53.16M – -29.54M
+14.9% YoY
|
-50.77M
-56.94M – -44.59M
-16.2% YoY
|
-70.86M
-90.25M – -51.48M
-39.6% YoY
|
-47.52M
-62.69M – -26.93M
+32.9% YoY
|
-2.40M
-3.17M – -1.36M
+94.9% YoY
|
| SGA |
14.36M
est: 9.09M (+58.1%)
|
23.00M
est: 23.00M (0.0%)
|
14.23M
est: 9.95M (+43.0%)
|
8.01M
est: 15.88M (-49.6%)
|
5.76M
est: 10.19M (-43.5%)
|
8.22M
est: 7.20M (+14.1%)
|
11.84M
est: 5.87M (+101.6%)
|
13.18M
est: 7.46M (+76.6%)
|
13.04M
est: 18.10M (-28.0%)
|
12.48M
est: 17.00M (-26.6%)
|
14.22M
est: 12.39M (+14.8%)
|
9.20M
6.66M – 10.94M
-25.8% YoY
|
7.83M
4.75M – 10.20M
-14.9% YoY
|
2.72M
1.81M – 3.39M
-65.2% YoY
|
2.76B
1.84B – 3.44B
+101,407.5% YoY
|
8.40B
5.60B – 10.46B
+203.8% YoY
|
| EPS |
-75.49
est: -75.48 (0.0%)
|
-93.54
est: -95.76 (+2.3%)
|
-51.71
est: -57.60 (+10.2%)
|
-7.06
est: -8.10 (+12.8%)
|
-2.70
est: -2.99 (+9.7%)
|
-1.08
est: -1.03 (-5.1%)
|
-0.73
est: -0.66 (-10.1%)
|
-0.89
est: -0.93 (+4.0%)
|
-0.93
est: -0.91 (-1.7%)
|
-0.95
est: -0.99 (+3.9%)
|
-0.69
est: -0.77 (+10.2%)
|
-0.59
-0.80 – -0.44
+23.3% YoY
|
-0.76
-0.85 – -0.67
-28.9% YoY
|
-1.17
-1.35 – -0.77
-54.3% YoY
|
-0.71
-0.94 – -0.40
+39.4% YoY
|
-0.04
-0.05 – -0.02
+94.9% YoY
|
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-11 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 2/5 |
| 2026-05-08 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 2/5 |
| 2026-05-07 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 2/5 |
| 2026-05-06 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 2/5 |
| 2026-05-05 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 2/5 |
| 2026-05-04 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 2/5 |
| 2026-05-01 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 2/5 |
| 2026-04-30 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 2/5 |
| 2026-04-29 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 2/5 |
| 2026-04-28 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 2/5 |
| 2026-04-27 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 2/5 |
| 2026-04-24 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-04-23 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-04-22 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-04-21 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-04-20 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-04-17 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-04-16 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
-38.42M
OE per share TTM
-0.66
Owner's Yield
-35.26%
Maintenance CapEx ratio
—
Maint CapEx / Avg PPE
496.0%
Ownership Overview
Ownership breakdown
At a glance
Institutional holders
46
Total invested
10.88M
Insider transactions (90d)
1
Beneficial owners (>5%)
31
Beneficial owners (>5%)
| # | Reporting person | Amount owned | % of class | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Type | Citizenship | Filing date | SEC filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | EIN #00-0000000 | 3.52M | 8.40% | — | 3.52M | — | 3.52M | IA, HC | Jersey, Channel Islands | 2022-02-10 | ↗ |
| 2 | Bruce S. Kovner | 3.48M | 8.10% | — | 3.48M | — | 3.48M | IN | Delaware | 2022-02-14 | ↗ |
| 3 | Caxton Corporation | 3.48M | 8.10% | — | 3.48M | — | 3.48M | CO | Delaware | 2022-02-14 | ↗ |
| 4 | CDK Associates, L.L.C. | 3.27M | 7.60% | — | 3.27M | — | 3.27M | OO | Delaware | 2022-02-14 | ↗ |
| 5 | Acorn Bioventures, L.P. | 3.04M | 6.38% | 3.04M | — | 3.04M | — | PN | Delaware | 2023-01-26 | ↗ |
| 6 | Acorn Capital Advisors GP, LLC | 3.04M | 6.38% | 3.04M | — | 3.04M | — | OO | Delaware | 2023-01-26 | ↗ |
| 7 | Anders Hove | 3.04M | 6.38% | 3.04M | — | 3.04M | — | IN | United States of America | 2023-01-26 | ↗ |
| 8 | (1) BlackRock, Inc. | 2.74M | 5.90% | 2.71M | — | — | 2.71M | HC | Delaware | 2024-11-08 | ↗ |
| 9 | SSGA FUNDS MANAGEMENT, INC. | 2.54M | 7.18% | — | 2.54M | — | 2.54M | IA | BOSTON, MASSACHUSETTS | 2021-02-11 | ↗ |
| 10 | PFIZER INC. | 2.41M | 5.75% | 2.41M | — | 2.41M | — | CO | Citizenship or Place of Organization Delaware | 2021-11-19 | ↗ |
| 11 | Koh, Bong | 1.71M | 5.70% | — | 1.71M | — | 1.71M | IN | United States | 2020-11-04 | ↗ |
| 12 | Shah, Nimish | 1.71M | 5.70% | — | 1.71M | — | 1.71M | IN | United States | 2020-11-04 | ↗ |
| 13 | VHCP Co-Investment Holdings III, LLC | 1.71M | 5.70% | — | 1.71M | — | 1.71M | OO | Delaware | 2020-11-04 | ↗ |
| 14 | VHCP Management EG, LLC | 1.71M | 5.70% | — | 1.71M | — | 1.71M | OO | Delaware | 2020-11-04 | ↗ |
| 15 | VHCP Management III, LLC | 1.71M | 5.70% | — | 1.71M | — | 1.71M | OO | Delaware | 2020-11-04 | ↗ |
| 16 | Venrock Healthcare Capital Partners EG, L.P. | 1.71M | 5.70% | — | 1.71M | — | 1.71M | PN | Delaware | 2020-11-04 | ↗ |
| 17 | Venrock Healthcare Capital Partners III, L.P. | 1.71M | 5.70% | — | 1.71M | — | 1.71M | PN | Delaware | 2020-11-04 | ↗ |
| 18 | STATE STREET CORPORATION | 693.4K | 1.65% | — | 653.5K | — | 693.4K | HC | BOSTON, MASSACHUSETTS | 2022-02-09 | ↗ |
| 19 | Avidity Capital Partners (GP) LLC | — | 0.00% | — | — | — | — | OO | Delaware | 2022-02-14 | ↗ |
| 20 | Avidity Capital Partners Fund (GP) LP | — | 0.00% | — | — | — | — | PN, OO | Delaware | 2022-02-14 | ↗ |
| 21 | Avidity Master Fund LP | — | 0.00% | — | — | — | — | PN, OO | Delaware | 2022-02-14 | ↗ |
| 22 | Avidity Partners Management (GP) LLC | — | 0.00% | — | — | — | — | OO | Delaware | 2022-02-14 | ↗ |
| 23 | Avidity Partners Management LP | — | 0.00% | — | — | — | — | IA, PN | Delaware | 2022-02-14 | ↗ |
| 24 | Corriente Advisors, LLC | — | 0.00% | — | — | — | — | OO | Citizenship or place of organization | 2022-02-14 | ↗ |
| 25 | Corriente Master Fund II, LP | — | 0.00% | — | — | — | — | PN | Citizenship or place of organization | 2022-02-14 | ↗ |
| 26 | David Witzke | — | 0.00% | — | — | — | — | IN | Delaware | 2022-02-14 | ↗ |
| 27 | Mark L. Hart III | — | 0.00% | — | — | — | — | IN | Citizenship or place of organization | 2022-02-14 | ↗ |
| 28 | Michael Gregory | — | 0.00% | — | — | — | — | IN | Delaware | 2022-02-14 | ↗ |
| 29 | Peter Kolchinsky | — | 0.00% | — | — | — | — | HC, IN | Delaware | 2021-02-10 | ↗ |
| 30 | RA Capital Management, L.P. | — | 0.00% | — | — | — | — | IA, PN | Delaware | 2021-02-10 | ↗ |
| 31 | Rajeev Shah | — | 0.00% | — | — | — | — | HC, IN | Delaware | 2021-02-10 | ↗ |
Institutional Activity (13F)
Institutional ownership trend
From
To
13F snapshot — 2026 Q1
Investors holding
46
-67 vs prev Q
New positions
9
Closed positions
72
Increased
17
Reduced
15
Put/Call ratio
0.00
Calls held
—
Puts held
—
Top institutional holders
| # | Investor | Shares / Δ | Mkt value / Δ | Own% / Δ | Weight% / Δ | Avg px / Perf. | Hold / Status |
|---|---|---|---|---|---|---|---|
| 1 | BLACKROCK, INC. | 4.04M +58.1K (+1.5%) | 11.36M +3.2M (+38.4%) | 6.05% +0.055 pp | 0.00% +0.000 pp | USD2.84 -1.1% | 6 qtrs — |
| 2 | VANGUARD GROUP INC | 3.72M +133.2K (+3.7%) | 10.46M +3.1M (+41.5%) | 5.57% +0.171 pp | 0.00% +0.000 pp | USD7.08 -60.3% | 23 qtrs — |
| 3 | LAURION CAPITAL MANAGEMENT LP | 2.65M +180.9K (+7.3%) | 7.44M +2.4M (+46.4%) | 3.96% +0.251 pp | 0.28% +0.190 pp | USD3.11 -9.6% | 5 qtrs — |
| 4 | PFIZER INC | 2.41M +— (+0.0%) | 6.78M +1.8M (+36.4%) | 3.61% -0.019 pp | 2.87% +1.730 pp | USD4.34 -35.3% | 5 qtrs — |
| 5 | ACORN CAPITAL ADVISORS, LLC | 1.96M +— (+0.0%) | 5.51M +1.5M (+36.4%) | 2.93% -0.016 pp | 1.87% -0.184 pp | USD3.70 -24.1% | 5 qtrs — |
| 6 | BLAIR WILLIAM & CO/IL | 1.95M -264.8K (-12.0%) | 5.48M +916.2K (+20.1%) | 2.91% -0.413 pp | 0.01% +0.003 pp | USD3.24 -13.3% | 18 qtrs — |
| 7 | GEODE CAPITAL MANAGEMENT, LLC | 1.52M -20.3K (-1.3%) | 4.28M +1.1M (+34.6%) | 2.28% -0.043 pp | 0.00% +0.000 pp | USD4.15 -32.3% | 23 qtrs — |
| 8 | FRANKLIN RESOURCES INC | 1.21M +1.2M (+100.0%) | 3.39M +3.4M (+100.0%) | 1.80% +1.803 pp | 0.00% +0.001 pp | USD2.81 +0.0% | 1 qtrs NEW |
| 9 | STATE STREET CORP | 1.19M +45.3K (+4.0%) | 3.35M +987.0K (+41.8%) | 1.78% +0.059 pp | 0.00% +0.000 pp | USD2.93 -4.1% | 21 qtrs — |
| 10 | TWO SIGMA INVESTMENTS, LP | 725.0K +520.9K (+255.4%) | 2.04M +1.6M (+384.7%) | 1.08% +0.777 pp | 0.00% +0.002 pp | USD2.83 -0.7% | 21 qtrs — |
| 11 | FLPUTNAM INVESTMENT MANAGEMENT CO | 595.3K -1.9K (-0.3%) | 1.67M +442.6K (+36.0%) | 0.89% -0.008 pp | 0.02% +0.006 pp | USD2.16 +30.1% | 3 qtrs — |
| 12 | NORTHERN TRUST CORP | 461.8K -58.0K (-11.2%) | 1.30M +226.8K (+21.2%) | 0.69% -0.091 pp | 0.00% +0.000 pp | USD3.47 -19.0% | 23 qtrs — |
| 13 | GOLDMAN SACHS GROUP INC | 385.1K -69.6K (-15.3%) | 1.08M +145.4K (+15.5%) | 0.58% -0.108 pp | 0.00% +0.000 pp | USD2.59 +8.5% | 8 qtrs — |
| 14 | TWO SIGMA ADVISERS, LP | 360.5K +334.7K (+1,297.3%) | 1.01M +959.9K (+1,806.0%) | 0.54% +0.500 pp | 0.00% +0.002 pp | USD2.83 -0.7% | 21 qtrs — |
| 15 | CANDRIAM S.C.A. | 344.4K +344.4K (+100.0%) | 967.9K +967.9K (+100.0%) | 0.52% +0.515 pp | 0.00% +0.005 pp | USD2.81 +0.0% | 1 qtrs NEW |
| 16 | BANK OF NEW YORK MELLON CORP | 329.0K -18.5K (-5.3%) | 924.5K +208.7K (+29.1%) | 0.49% -0.030 pp | 0.00% +0.000 pp | USD3.07 -8.5% | 22 qtrs — |
| 17 | MORGAN STANLEY | 235.8K -74.8K (-24.1%) | 662.7K +22.7K (+3.6%) | 0.35% -0.114 pp | 0.00% +0.000 pp | USD2.85 -1.4% | 23 qtrs — |
| 18 | XTX TOPCO LTD | 219.4K +63.2K (+40.5%) | 616.4K +294.7K (+91.6%) | 0.33% +0.093 pp | 0.02% -0.001 pp | USD2.92 -3.8% | 9 qtrs — |
| 19 | GSA CAPITAL PARTNERS LLP | 210.9K +210.9K (+100.0%) | 593.0K +593.0K (+100.0%) | 0.32% +0.315 pp | 0.05% +0.051 pp | USD2.81 +0.0% | 7 qtrs — |
| 20 | MILLENNIUM MANAGEMENT LLC | 194.4K +158.5K (+441.5%) | 546.3K +472.4K (+638.7%) | 0.29% +0.237 pp | 0.00% +0.000 pp | USD2.99 -6.0% | 8 qtrs — |
| 21 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 188.7K -660.0 (-0.3%) | 530.1K +140.1K (+35.9%) | 0.28% -0.003 pp | 0.00% +0.000 pp | USD2.91 -3.4% | 19 qtrs — |
| 22 | AVESTAR CAPITAL, LLC | 136.1K -4.3K (-3.1%) | 382.6K +93.2K (+32.2%) | 0.20% -0.008 pp | 0.02% +0.006 pp | USD2.05 +37.1% | 7 qtrs — |
| 23 | JANE STREET GROUP, LLC | 132.9K -29.1K (-18.0%) | 373.3K +39.7K (+11.9%) | 0.20% -0.045 pp | 0.00% +0.000 pp | USD2.06 +36.4% | 2 qtrs — |
| 24 | CITADEL ADVISORS LLC | 118.2K +95.8K (+428.5%) | 332.1K +286.0K (+620.8%) | 0.18% +0.143 pp | 0.00% +0.000 pp | USD2.67 +5.2% | 22 qtrs — |
| 25 | ALPHACORE CAPITAL LLC | 114.4K +4.5K (+4.1%) | 321.5K +95.1K (+42.0%) | 0.17% +0.006 pp | 0.01% 0.000 pp | USD3.06 -8.2% | 3 qtrs — |
| 26 | BARCLAYS PLC | 98.9K +45.8K (+86.2%) | 277.8K +136.1K (+96.0%) | 0.15% +0.068 pp | 0.00% +0.000 pp | USD2.88 -2.4% | 7 qtrs — |
| 27 | UBS GROUP AG | 87.4K -118.7K (-57.6%) | 245.7K -179.0K (-42.2%) | 0.13% -0.179 pp | 0.00% +0.000 pp | USD3.44 -18.3% | 18 qtrs — |
| 28 | WELLS FARGO & COMPANY/MN | 83.8K +25.3K (+43.3%) | 235.6K +115.0K (+95.4%) | 0.13% +0.037 pp | 0.00% +0.000 pp | USD2.77 +1.4% | 22 qtrs — |
| 29 | NUVEEN, LLC | 80.2K -114.1K (-58.7%) | 225.4K -174.9K (-43.7%) | 0.12% -0.172 pp | 0.00% +0.000 pp | USD3.14 -10.5% | 4 qtrs — |
| 30 | RHUMBLINE ADVISERS | 78.4K -8.9K (-10.2%) | 220.3K +40.5K (+22.5%) | 0.12% -0.014 pp | 0.00% +0.000 pp | USD2.72 +3.3% | 7 qtrs — |
| 31 | HB WEALTH MANAGEMENT, LLC | 71.5K -448.0 (-0.6%) | 200.9K +52.7K (+35.6%) | 0.11% -0.001 pp | 0.00% +0.000 pp | USD2.06 +36.4% | 5 qtrs — |
| 32 | ASSENAGON ASSET MANAGEMENT S.A. | 67.2K +— (+0.0%) | 188.9K +50.4K (+36.4%) | 0.10% -0.001 pp | 0.00% +0.000 pp | USD2.82 -0.4% | 16 qtrs — |
| 33 | ROCKEFELLER CAPITAL MANAGEMENT L.P. | 56.5K -6.0K (-9.6%) | 158.8K +30.0K (+23.3%) | 0.08% -0.010 pp | 0.00% +0.000 pp | USD2.06 +36.4% | 2 qtrs — |
| 34 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | 56.4K -38.9K (-40.8%) | 158.5K -37.8K (-19.3%) | 0.08% -0.059 pp | 0.00% +0.000 pp | USD2.27 +23.8% | 22 qtrs — |
| 35 | DIMENSIONAL FUND ADVISORS LP | 55.7K +12.0 (+0.0%) | 156.5K +41.8K (+36.4%) | 0.08% 0.000 pp | 0.00% +0.000 pp | USD2.45 +14.7% | 15 qtrs — |
| 36 | MAI CAPITAL MANAGEMENT | 51.6K -14.7K (-22.2%) | 145.0K +8.4K (+6.2%) | 0.08% -0.023 pp | 0.00% +0.000 pp | USD3.12 -9.9% | 10 qtrs — |
| 37 | CAPSTONE INVESTMENT ADVISORS, LLC | 51.2K +— (+0.0%) | 143.8K +38.4K (+36.4%) | 0.08% 0.000 pp | 0.00% +0.000 pp | USD17.74 -84.2% | 21 qtrs — |
| 38 | ALLIANCEBERNSTEIN L.P. | 48.7K +7.0 (+0.0%) | 137.0K +36.6K (+36.4%) | 0.07% 0.000 pp | 0.00% +0.000 pp | USD2.92 -3.8% | 7 qtrs — |
| 39 | DEUTSCHE BANK AG\ | 43.9K +43.1K (+5,767.4%) | 123.3K +121.8K (+7,902.9%) | 0.07% +0.065 pp | 0.00% +0.000 pp | USD2.84 -1.1% | 5 qtrs — |
| 40 | GLENVIEW TRUST CO | 43.1K +— (+0.0%) | 121.2K +32.3K (+36.4%) | 0.06% 0.000 pp | 0.00% +0.001 pp | USD3.81 -26.2% | 5 qtrs — |
| 41 | GROUP ONE TRADING, L.P. | 41.9K +41.9K (+100.0%) | 117.7K +117.7K (+100.0%) | 0.06% +0.063 pp | 0.00% +0.000 pp | USD2.81 +0.0% | 19 qtrs — |
| 42 | BANK OF AMERICA CORP /DE/ | 41.3K -8.1K (-16.3%) | 116.0K +14.4K (+14.1%) | 0.06% -0.012 pp | 0.00% +0.000 pp | USD3.13 -10.2% | 22 qtrs — |
| 43 | VIRTU FINANCIAL LLC | 38.5K +38.5K (+100.0%) | 108.0K +108.0K (+100.0%) | 0.06% +0.058 pp | 0.00% +0.004 pp | USD2.81 +0.0% | 1 qtrs NEW |
| 44 | ELKHORN PARTNERS LIMITED PARTNERSHIP | 38.1K -900.0 (-2.3%) | 107.1K +26.7K (+33.3%) | 0.06% -0.002 pp | 0.07% +0.013 pp | USD2.71 +3.7% | 23 qtrs — |
| 45 | FMR LLC | 37.7K +5.5K (+17.1%) | 105.9K +39.6K (+59.7%) | 0.06% +0.008 pp | 0.00% +0.000 pp | USD3.11 -9.6% | 7 qtrs — |
| 46 | CREATIVE PLANNING | 37.5K -2.6K (-6.6%) | 105.2K +22.6K (+27.4%) | 0.06% -0.004 pp | 0.00% +0.000 pp | USD2.85 -1.4% | 14 qtrs — |
| 47 | INVST, LLC | 36.0K -4.5K (-11.1%) | 101.2K +17.7K (+21.3%) | 0.05% -0.007 pp | 0.01% +0.002 pp | USD2.81 +0.0% | 7 qtrs — |
| 48 | HIGHTOWER ADVISORS, LLC | 34.2K +— (+0.0%) | 96.1K +25.7K (+36.4%) | 0.05% 0.000 pp | 0.00% +0.000 pp | USD3.36 -16.4% | 14 qtrs — |
| 49 | PRICE T ROWE ASSOCIATES INC /MD/ | 31.3K +— (+0.0%) | 89.0K +24.0K (+36.9%) | 0.05% 0.000 pp | 0.00% +0.000 pp | USD3.41 -17.6% | 17 qtrs — |
| 50 | HRT FINANCIAL LP | 29.4K +15.1K (+105.1%) | 82.0K +53.0K (+182.8%) | 0.04% +0.022 pp | 0.00% +0.000 pp | USD2.44 +15.2% | 2 qtrs — |
| 51 | MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 28.8K -38.0 (-0.1%) | 80.8K +21.5K (+36.2%) | 0.04% 0.000 pp | 0.00% +0.000 pp | USD2.88 -2.4% | 6 qtrs — |
| 52 | INTECH INVESTMENT MANAGEMENT LLC | 28.0K +— (+0.0%) | 78.7K +21.0K (+36.4%) | 0.04% 0.000 pp | 0.00% +0.000 pp | USD3.85 -27.0% | 5 qtrs — |
| 53 | RAYMOND JAMES FINANCIAL INC | 26.7K +3.0K (+12.9%) | 74.9K +26.3K (+54.0%) | 0.04% +0.004 pp | 0.00% +0.000 pp | USD3.27 -14.1% | 5 qtrs — |
| 54 | JPMORGAN CHASE & CO | 26.0K +1.0K (+4.0%) | 73.0K +21.6K (+41.9%) | 0.04% +0.001 pp | 0.00% +0.000 pp | USD2.63 +6.8% | 11 qtrs — |
| 55 | GOLDEN STATE EQUITY PARTNERS | 24.5K +24.5K (+100.0%) | 68.8K +68.8K (+100.0%) | 0.04% +0.037 pp | 0.01% +0.011 pp | USD2.81 +0.0% | 1 qtrs NEW |
| 56 | POST RESCH TALLON GROUP INC. | 22.5K -35.0 (-0.2%) | 63.2K +16.8K (+36.2%) | 0.03% 0.000 pp | 0.05% +0.012 pp | USD2.06 +36.4% | 2 qtrs — |
| 57 | UNITED BANK | 22.4K +— (+0.0%) | 63.0K +16.8K (+36.4%) | 0.03% 0.000 pp | 0.01% +0.003 pp | USD2.62 +7.3% | 9 qtrs — |
| 58 | INVESCO LTD. | 22.2K -3.1K (-12.3%) | 62.3K +10.3K (+19.7%) | 0.03% -0.005 pp | 0.00% +0.000 pp | USD2.36 +19.1% | 7 qtrs — |
| 59 | BAKER ELLIS ASSET MANAGEMENT LLC | 20.0K +— (+0.0%) | 56.2K +15.0K (+36.4%) | 0.03% 0.000 pp | 0.01% +0.002 pp | USD2.67 +5.2% | 6 qtrs — |
| 60 | MANUFACTURERS LIFE INSURANCE COMPANY, THE | 19.4K +5.7K (+41.5%) | 54.6K +26.3K (+93.0%) | 0.03% +0.008 pp | 0.00% +0.000 pp | USD3.64 -22.8% | 5 qtrs — |
| 61 | FINDEC WEALTH SERVICES, INC. | 16.0K +— (+0.0%) | 45.0K +12.0K (+36.4%) | 0.02% 0.000 pp | 0.05% +0.014 pp | USD1.40 +100.7% | 13 qtrs — |
| 62 | SG AMERICAS SECURITIES, LLC | 15.8K +15.8K (+100.0%) | 44.0K +44.0K (+100.0%) | 0.02% +0.024 pp | 0.00% +0.000 pp | USD2.81 +0.0% | 1 qtrs NEW |
| 63 | SKOPOS LABS, INC. | 12.6K +66.0 (+0.5%) | 37.3K +11.4K (+44.0%) | 0.02% +0.000 pp | 0.00% -0.001 pp | USD2.06 +36.4% | 2 qtrs — |
| 64 | GLADSTONE INSTITUTIONAL ADVISORY LLC | 13.0K +— (+0.0%) | 36.5K +9.8K (+36.4%) | 0.02% 0.000 pp | 0.00% +0.000 pp | USD1.53 +83.7% | 14 qtrs — |
| 65 | BROKERS INTERNATIONAL FINANCIAL SERVICES, LLC. | 12.9K +— (+0.0%) | 36.1K +9.6K (+36.4%) | 0.02% 0.000 pp | 0.00% +0.000 pp | USD3.15 -10.8% | 3 qtrs — |
| 66 | R SQUARED LTD | 12.7K +12.7K (+100.0%) | 35.7K +35.7K (+100.0%) | 0.02% +0.019 pp | 0.02% +0.017 pp | USD2.81 +0.0% | 1 qtrs NEW |
| 67 | BNP PARIBAS ARBITRAGE, SNC | 12.6K +1.1K (+9.1%) | 35.5K +11.7K (+48.9%) | 0.02% +0.002 pp | 0.00% +0.000 pp | USD3.37 -16.6% | 5 qtrs — |
| 68 | VOYA INVESTMENT MANAGEMENT LLC | 12.6K +— (+0.0%) | 35.3K +9.4K (+36.4%) | 0.02% 0.000 pp | 0.00% +0.000 pp | USD4.02 -30.1% | 5 qtrs — |
| 69 | PFG INVESTMENTS, LLC | 12.5K +— (+0.0%) | 35.1K +9.4K (+36.4%) | 0.02% 0.000 pp | 0.00% +0.000 pp | USD4.99 -43.7% | 8 qtrs — |
| 70 | BELPOINTE ASSET MANAGEMENT LLC | 11.8K +25.0 (+0.2%) | 33.1K +8.9K (+36.7%) | 0.02% 0.000 pp | 0.00% +0.000 pp | USD3.13 -10.2% | 4 qtrs — |
| 71 | TAMAR SECURITIES, LLC | 11.5K +11.5K (+100.0%) | 32.3K +32.3K (+100.0%) | 0.02% +0.017 pp | 0.00% +0.003 pp | USD2.81 +0.0% | 1 qtrs NEW |
| 72 | PROSHARE ADVISORS LLC | 11.3K +728.0 (+6.9%) | 31.8K +10.0K (+45.8%) | 0.02% +0.001 pp | 0.00% +0.000 pp | USD4.13 -32.0% | 5 qtrs — |
| 73 | LEDGEWOOD WEALTH ADVISORS, LLC | 11.2K +— (+0.0%) | 31.4K +8.4K (+36.4%) | 0.02% 0.000 pp | 0.02% +0.005 pp | USD3.14 -10.5% | 4 qtrs — |
| 74 | LIDO ADVISORS, LLC | 15.0K +— (+0.0%) | 30.9K +— (+0.0%) | 0.02% 0.000 pp | 0.00% +0.000 pp | USD3.15 -10.8% | 3 qtrs — |
| 75 | SCARBOROUGH ADVISORS, LLC | 10.5K +— (+0.0%) | 29.5K +7.9K (+36.4%) | 0.02% 0.000 pp | 0.01% +0.001 pp | USD2.84 -1.1% | 3 qtrs — |
| 76 | CAPITAL ADVISORS WEALTH MANAGEMENT, LLC | 10.5K +10.5K (+100.0%) | 29.5K +29.5K (+100.0%) | 0.02% +0.016 pp | 0.00% +0.004 pp | USD2.81 +0.0% | 1 qtrs NEW |
| 77 | PROACTIVE WEALTH STRATEGIES LLC | 10.0K +— (+0.0%) | 28.1K +7.5K (+36.4%) | 0.02% 0.000 pp | 0.01% +0.002 pp | USD2.06 +36.4% | 2 qtrs — |
| 78 | SECURITY NATIONAL BANK | 9.8K +— (+0.0%) | 27.4K +7.3K (+36.4%) | 0.01% 0.000 pp | 0.00% +0.001 pp | USD1.48 +89.9% | 9 qtrs — |
| 79 | POLICE & FIREMEN'S RETIREMENT SYSTEM OF NEW JERSEY | 8.0K -15.8K (-66.4%) | 22.4K -26.5K (-54.2%) | 0.01% -0.024 pp | 0.00% 0.000 pp | USD3.11 -9.6% | 5 qtrs — |
| 80 | HURLEY CAPITAL, LLC | 7.1K +— (+0.0%) | 20.0K +5.3K (+36.4%) | 0.01% 0.000 pp | 0.01% +0.003 pp | USD2.06 +36.4% | 2 qtrs — |
| 81 | SAGEVIEW ADVISORY GROUP, LLC | 6.5K +6.5K (+100.0%) | 18.2K +18.2K (+100.0%) | 0.01% +0.010 pp | 0.00% +0.001 pp | USD2.81 +0.0% | 1 qtrs NEW |
| 82 | METLIFE INVESTMENT MANAGEMENT, LLC | 6.2K +6.2K (+100.0%) | 17.5K +17.5K (+100.0%) | 0.01% +0.009 pp | 0.00% +0.000 pp | USD2.81 +0.0% | 5 qtrs — |
| 83 | LEGAL & GENERAL GROUP PLC | 6.2K +— (+0.0%) | 17.4K +4.6K (+36.4%) | 0.01% +0.000 pp | 0.00% +0.000 pp | USD2.47 +13.8% | 7 qtrs — |
| 84 | TOWER RESEARCH CAPITAL LLC (TRC) | 6.0K -3.8K (-38.5%) | 16.8K -3.2K (-16.2%) | 0.01% -0.006 pp | 0.00% 0.000 pp | USD2.79 +0.7% | 12 qtrs — |
| 85 | AMERITAS INVESTMENT PARTNERS, INC. | 5.7K +— (+0.0%) | 16.0K +4.3K (+36.4%) | 0.01% +0.000 pp | 0.00% +0.000 pp | USD2.05 +37.1% | 7 qtrs — |
| 86 | RUSSELL INVESTMENTS GROUP, LTD. | 5.1K +— (+0.0%) | 14.4K +3.9K (+36.4%) | 0.01% +0.000 pp | 0.00% +0.000 pp | USD2.06 +36.4% | 2 qtrs — |
| 87 | CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | 3.8K -54.0 (-1.4%) | 10.7K +2.8K (+34.5%) | 0.01% 0.000 pp | 0.00% +0.000 pp | USD2.41 +16.6% | 7 qtrs — |
| 88 | NEW YORK STATE COMMON RETIREMENT FUND | 3.6K +— (+0.0%) | 10.1K +2.7K (+36.4%) | 0.01% +0.000 pp | 0.00% +0.000 pp | USD2.05 +37.1% | 7 qtrs — |
| 89 | US BANCORP \DE\ | 3.1K +— (+0.0%) | 8.7K +2.3K (+36.4%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD2.63 +6.8% | 13 qtrs — |
| 90 | STERLING CAPITAL MANAGEMENT LLC | 2.5K +119.0 (+5.1%) | 6.9K +2.1K (+43.4%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD2.81 +0.0% | 6 qtrs — |
| 91 | AMALGAMATED BANK | 1.9K -61.0 (-3.0%) | 5.0K +1.0K (+25.0%) | 0.00% 0.000 pp | 0.00% +0.000 pp | USD2.40 +17.1% | 7 qtrs — |
| 92 | ROYAL BANK OF CANADA | 1.7K -114.7K (-98.5%) | 4.0K -237.0K (-98.3%) | 0.00% -0.172 pp | 0.00% +0.000 pp | USD3.41 -17.6% | 8 qtrs — |
| 93 | CITIGROUP INC | 1.4K -219.0 (-13.5%) | 3.9K +600.0 (+18.0%) | 0.00% 0.000 pp | 0.00% +0.000 pp | USD3.56 -21.1% | 8 qtrs — |
| 94 | NBC SECURITIES, INC. | 1.0K +— (+0.0%) | 2.8K +750.0 (+36.4%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD3.14 -10.5% | 4 qtrs — |
| 95 | GAMMA INVESTING LLC | 746.00 +746.0 (+100.0%) | 2.1K +2.1K (+100.0%) | 0.00% +0.001 pp | 0.00% +0.000 pp | USD2.81 +0.0% | 1 qtrs NEW |
| 96 | CLEARSTEAD ADVISORS, LLC | 700.00 +— (+0.0%) | 2.0K +525.0 (+36.4%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD2.05 +37.1% | 7 qtrs — |
Ownership breakdown by holder
ETF Ownership
Top ETFs holding this stock
Held by 18 ETFs in our universe
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | iShares Micro-Cap ETF IWC | 0.02% | 294.8K | 0.60% |
| 2 | Vanguard Russell 2000 Value ETF VTWV | 0.00% | 52.0K | 0.06% |
| 3 | Vanguard Russell 2000 ETF VTWO | 0.00% | 602.6K | 0.06% |
| 4 | Vanguard Russell 2000 Growth ETF VTWG | 0.00% | 53.5K | 0.06% |
| 5 | Vanguard Extended Market ETF VXF | 0.00% | 1.41M | 0.05% |
| 6 | Vanguard U.S. Total Market Index ETF VUN.TO | 0.00% | 22.9K | 0.17% |
| 7 | Vanguard U.S. Total Market Shares Index ETF VTS.AX | 0.00% | 8.3K | 0.03% |
| 8 | Vanguard U.S. Total Market Index ETF (CAD-hedged) VUS.TO | 0.00% | 1.7K | 0.17% |
| 9 | Vanguard Total Stock Market ETF VTI | 0.00% | 3.92M | 0.03% |
| 10 | Vanguard Russell 3000 ETF VTHR | 0.00% | 7.5K | 0.06% |
Insider Activity
Insider Activity — Latest Quarter
Ratio by transactions
0.00
Bearish
Buys
3
Sells
0
Shares acquired
1.19M
Shares disposed
—
Cash buys
—
Cash sales
—
Net activity
+1,186,650
Insider buys vs sells (history)
From
To
Recent insider transactions
From
To
| Date | Person | Role | Transaction | A/D | Security | Shares | Price | Value | Owned after | D/I | Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-04-27 | Aggarwal Ajay | Officer | A-Award | A | Stock Options | 400,000 | 1.72 | 688.0K | 400,000 | D | ↗ |
| 2026-04-14 | Smeal Tod | Officer | A-Award | A | Stock Options | 300,000 | 1.63 | 489.0K | 1,279,805 | D | ↗ |
| 2026-04-06 | Muntner Joshua B | Officer | — | — | Common Stock | 0 | 0.00 | — | 500 | D | ↗ |
| 2026-03-31 | Mohindru Mani | Director / Officer | A-Award | A | Stock Options | 600,000 | 1.62 | 972.0K | 968,766 | D | ↗ |
| 2026-02-17 | Mohindru Mani | Director / Officer | A-Award | A | Stock Options | 200,000 | 1.56 | 312.0K | 368,766 | D | ↗ |
| 2026-02-13 | Lindsay Brigitte Ute | Officer | A-Award | A | Stock Options | 200,000 | 1.60 | 320.0K | 1,025,334 | D | ↗ |
| 2026-01-27 | Lindsay Brigitte Ute | Officer | — | — | Stock Options | 89,469 | 2.48 | 221.9K | 0 | D | ↗ |
| 2025-07-30 | PACE GARY W | Director | P-Purchase | A | Common Stock | 15,000 | 2.45 | 36.8K | 1,345,676 | I | ↗ |
| 2025-06-26 | White Lale | Director | A-Award | A | Stock Options | 40,565 | 3.16 | 128.2K | 158,681 | D | ↗ |
| 2025-06-26 | TANNENBAUM RENEE P | Director | A-Award | A | Stock Options | 40,565 | 3.16 | 128.2K | 168,766 | D | ↗ |
| 2025-06-26 | PACE GARY W | Director | A-Award | A | Stock Options | 40,565 | 3.16 | 128.2K | 187,539 | D | ↗ |
| 2025-06-26 | Mohindru Mani | Director | A-Award | A | Stock Options | 40,565 | 3.16 | 128.2K | 168,766 | D | ↗ |
| 2025-06-26 | Markin Rodney S | Director | A-Award | A | Stock Options | 40,565 | 3.16 | 128.2K | 222,865 | D | ↗ |
| 2025-06-26 | Armitage James O | Director | A-Award | A | Stock Options | 40,565 | 3.16 | 128.2K | 187,539 | D | ↗ |
| 2025-06-16 | Sidhu Roger | Officer | — | — | Employee Stock Option (right to buy) | 600,000 | 3.86 | 2.32M | 0 | D | ↗ |
| 2025-03-11 | Smeal Tod | Officer | A-Award | A | Stock Options | 332,621 | 3.58 | 1.19M | 979,805 | D | ↗ |
| 2025-03-11 | Levine James E. | Officer | A-Award | A | Stock Options | 332,621 | 3.58 | 1.19M | 1,295,117 | D | ↗ |
| 2025-03-11 | Kabbinavar Fairooz | Officer | A-Award | A | Stock Options | 150,000 | 3.58 | 537.0K | 780,008 | D | ↗ |
| 2025-03-11 | Erlander Mark | Director / Officer | A-Award | A | Stock Options | 758,400 | 3.58 | 2.72M | 2,925,098 | D | ↗ |
| 2024-12-18 | Levine James E. | Officer | P-Purchase | A | Common Stock | 2,400 | 5.00 | 12.0K | 67,716 | I | ↗ |
| 2024-12-17 | Levine James E. | Officer | P-Purchase | A | Common Stock | 2,752 | 5.42 | 14.9K | 65,316 | I | ↗ |
| 2024-12-16 | Levine James E. | Officer | P-Purchase | A | Common Stock | 2,564 | 3.83 | 9.8K | 62,564 | I | ↗ |
| 2024-12-12 | TANNENBAUM RENEE P | Director | P-Purchase | A | Common Stock | 10,000 | 3.42 | 34.2K | 20,000 | D | ↗ |
| 2024-12-11 | PACE GARY W | Director | P-Purchase | A | Common Stock | 11,500 | 2.60 | 29.9K | 1,059,376 | I | ↗ |
| 2024-06-27 | White Lale | Director | A-Award | A | Stock Options | 29,700 | 2.33 | 69.2K | 146,974 | — | ↗ |
| 2024-06-27 | TANNENBAUM RENEE P | Director | A-Award | A | Stock Options | 29,700 | 2.33 | 69.2K | 128,201 | — | ↗ |
| 2024-06-27 | PACE GARY W | Director | A-Award | A | Stock Options | 29,700 | 2.33 | 69.2K | 146,974 | — | ↗ |
| 2024-06-27 | Mohindru Mani | Director | A-Award | A | Stock Options | 29,700 | 2.33 | 69.2K | 128,201 | — | ↗ |
| 2024-06-27 | Markin Rodney S | Director | A-Award | A | Stock Options | 29,700 | 2.33 | 69.2K | 182,027 | — | ↗ |
| 2024-06-27 | Armitage James O | Director | A-Award | A | Stock Options | 29,700 | 2.33 | 69.2K | 146,974 | — | ↗ |
| 2024-03-07 | Smeal Tod | Officer | A-Award | A | Stock Options | 205,008 | 3.51 | 719.6K | 647,184 | — | ↗ |
| 2024-03-07 | Levine James E. | Officer | A-Award | A | Stock Options | 205,008 | 3.51 | 719.6K | 962,496 | — | ↗ |
| 2024-03-07 | Kabbinavar Fairooz | Officer | A-Award | A | Stock Options | 205,008 | 3.51 | 719.6K | 630,008 | — | ↗ |
| 2024-03-07 | Erlander Mark | Director / Officer | A-Award | A | Stock Options | 510,000 | 3.51 | 1.79M | 2,170,310 | — | ↗ |
| 2023-12-19 | PACE GARY W | Director | P-Purchase | A | Common Stock | 30,000 | 1.37 | 41.1K | 697,761 | — | ↗ |
| 2023-11-10 | PACE GARY W | Director | P-Purchase | A | Common Stock | 22,950 | 0.98 | 22.5K | 667,761 | — | ↗ |
| 2023-06-15 | White Lale | Director | A-Award | A | Stock Options | 27,700 | 1.59 | 44.0K | 117,274 | — | ↗ |
| 2023-06-15 | TANNENBAUM RENEE P | Director | A-Award | A | Stock Options | 27,700 | 1.59 | 44.0K | 98,501 | — | ↗ |
| 2023-06-15 | PACE GARY W | Director | A-Award | A | Stock Options | 27,700 | 1.59 | 44.0K | 117,274 | — | ↗ |
| 2023-06-15 | Mohindru Mani | Director | A-Award | A | Stock Options | 27,700 | 1.59 | 44.0K | 98,501 | — | ↗ |
| 2023-06-15 | Markin Rodney S | Director | A-Award | A | Stock Options | 27,700 | 1.59 | 44.0K | 152,327 | — | ↗ |
| 2023-06-15 | Armitage James O | Director | A-Award | A | Stock Options | 27,700 | 1.59 | 44.0K | 117,274 | — | ↗ |
| 2023-03-15 | Smeal Tod | Officer | A-Award | A | Stock Options | 167,088 | 1.72 | 287.4K | 442,176 | — | ↗ |
| 2023-03-15 | Levine James E. | Officer | A-Award | A | Stock Options | 197,472 | 1.72 | 339.7K | 757,488 | — | ↗ |
| 2023-03-15 | Kelemen Vicki | Officer | A-Award | A | Stock Options | 125,520 | 1.72 | 215.9K | 698,304 | — | ↗ |
| 2023-03-15 | Erlander Mark | Director / Officer | A-Award | A | Stock Options | 482,064 | 1.72 | 829.2K | 1,664,477 | — | ↗ |
| 2023-01-30 | Kabbinavar Fairooz | Officer | — | D | Stock Options | 425,000 | 1.75 | 743.8K | 0 | — | ↗ |
| 2022-11-25 | Erlander Mark | Officer | P-Purchase | A | Common Stock | 10,000 | 1.43 | 14.3K | 24,481 | — | ↗ |
| 2022-09-19 | White Lale | Director | P-Purchase | A | Common Stock | 15,000 | 1.64 | 24.5K | 113,788 | — | ↗ |
| 2022-09-16 | Levine James E. | Officer | P-Purchase | A | Common Stock | 30,000 | 1.56 | 46.7K | 60,000 | — | ↗ |
| 2022-09-16 | Armitage James O | Director | P-Purchase | A | Common Stock | 13,000 | 1.56 | 20.2K | 13,000 | — | ↗ |
| 2022-09-15 | TANNENBAUM RENEE P | Director | P-Purchase | A | Common Stock | 3,600 | 1.72 | 6.2K | 10,000 | — | ↗ |
| 2022-09-15 | PACE GARY W | Director | P-Purchase | A | Common Stock | 150,000 | 1.71 | 256.5K | 644,811 | — | ↗ |
| 2022-07-05 | White Lale | Director | M-Exempt | A | Common Stock | 28,858 | 2.60 | 75.0K | 98,788 | — | ↗ |
| 2022-06-09 | BRANCACCIO JOHN P | Director | J-Other | A | Stock Options | 195 | 316.08 | 61.6K | 125,317 | — | ↗ |
| 2022-03-09 | White Lale | Director | A-Award | A | Stock Options | 26,800 | 0.00 | — | 89,574 | — | ↗ |
| 2022-03-09 | TANNENBAUM RENEE P | Director | A-Award | A | Stock Options | 26,800 | 0.00 | — | 70,801 | — | ↗ |
| 2022-03-09 | Ruffner Katherine L | Officer | A-Award | A | Stock Options | 170,016 | 0.00 | — | 370,016 | — | ↗ |
| 2022-03-09 | PACE GARY W | Director | A-Award | A | Stock Options | 26,800 | 2.50 | 67.0K | 89,574 | — | ↗ |
| 2022-03-09 | Mohindru Mani | Director | A-Award | A | Stock Options | 26,800 | 2.50 | 67.0K | 70,801 | — | ↗ |
| 2022-03-09 | Markin Rodney S | Director | A-Award | A | Stock Options | 26,800 | 2.50 | 67.0K | 124,627 | — | ↗ |
| 2022-03-09 | Levine James E. | Officer | A-Award | A | Stock Options | 170,016 | 0.00 | — | 560,016 | — | ↗ |
| 2022-03-09 | Kelemen Vicki | Officer | A-Award | A | Stock Options | 170,016 | 2.50 | 425.0K | 572,784 | — | ↗ |
| 2022-03-09 | Erlander Mark | Director / Officer | A-Award | A | Stock Options | 370,128 | 2.50 | 925.3K | 1,185,400 | — | ↗ |
| 2022-03-09 | BRANCACCIO JOHN P | Director | A-Award | A | Stock Options | 26,800 | 2.50 | 67.0K | 125,317 | — | ↗ |
| 2022-03-09 | Armitage James O | Director | A-Award | A | Stock Options | 26,800 | 0.00 | — | 89,574 | — | ↗ |
| 2022-01-10 | Smeal Tod | Officer | — | D | Stock Options | 275,088 | 6.58 | 1.81M | 0 | — | ↗ |
| 2021-09-21 | PACE GARY W | Director | P-Purchase | A | Common Stock | 30,000 | 6.75 | 202.5K | 494,811 | — | ↗ |
| 2021-09-10 | Levine James E. | Officer | P-Purchase | A | Common Stock | 10,000 | 6.38 | 63.8K | 20,000 | — | ↗ |
| 2021-07-12 | Ruffner Katherine L | Officer | A-Award | A | Stock Options | 200,000 | 6.55 | 1.31M | 200,000 | — | ↗ |
| 2021-07-12 | Levine James E. | Officer | A-Award | A | Common Stock | 390,000 | 6.55 | 2.55M | 390,000 | — | ↗ |
| 2021-07-06 | Ruffner Katherine L | Officer | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2021-06-10 | White Lale | Director | A-Award | A | Stock Options | 22,000 | 7.98 | 175.6K | 62,774 | — | ↗ |
| 2021-06-10 | TANNENBAUM RENEE P | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2021-06-10 | PACE GARY W | Director | A-Award | A | Stock Options | 22,000 | 7.98 | 175.6K | 62,774 | — | ↗ |
| 2021-06-10 | Mohindru Mani | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2021-06-10 | Markin Rodney S | Director | A-Award | A | Stock Options | 22,000 | 7.98 | 175.6K | 97,827 | — | ↗ |
| 2021-06-10 | Kelemen Vicki | Officer | A-Award | A | Stock Options | 200,928 | 7.98 | 1.60M | 402,768 | — | ↗ |
| 2021-06-10 | JACOB GARY S | — | J-Other | A | Stock Options | 293 | 447.84 | 131.2K | 76,106 | — | ↗ |
| 2021-06-10 | Erlander Mark | Director / Officer | A-Award | A | Stock Options | 435,072 | 7.98 | 3.47M | 815,272 | — | ↗ |
| 2021-06-10 | BRANCACCIO JOHN P | Director | A-Award | A | Stock Options | 22,000 | 7.98 | 175.6K | 98,517 | — | ↗ |
| 2021-06-10 | Armitage James O | Director | A-Award | A | Stock Options | 22,000 | 7.98 | 175.6K | 62,774 | — | ↗ |
| 2021-06-10 | ADAMS THOMAS PHD | — | J-Other | A | Stock Options | 755 | 21.60 | 16.3K | 477,870 | — | ↗ |
| 2021-03-26 | Markin Rodney S | Director | P-Purchase | A | Common Stock | 2,900 | 10.32 | 29.9K | 23,879 | — | ↗ |
| 2021-03-23 | PACE GARY W | Director | P-Purchase | A | Common Stock | 2,500 | 10.31 | 25.8K | 464,811 | — | ↗ |
| 2021-03-23 | Kelemen Vicki | Officer | P-Purchase | A | Common Stock | 960 | 10.31 | 9.9K | 6,053 | — | ↗ |
| 2021-03-23 | JACOB GARY S | Director | P-Purchase | A | Common Stock | 470 | 10.40 | 4.9K | 21,922 | — | ↗ |
| 2021-03-23 | Erlander Mark | Officer | P-Purchase | A | Common Stock | 965 | 10.34 | 10.0K | 14,481 | — | ↗ |
| 2021-03-22 | BRANCACCIO JOHN P | Director | P-Purchase | A | Common Stock | 3,000 | 10.95 | 32.9K | 12,260 | — | ↗ |
| 2021-03-19 | Armitage James O | Director | P-Purchase | A | Common Stock | 4,000 | 10.82 | 43.3K | 14,490 | — | ↗ |
| 2021-03-18 | PACE GARY W | Director | P-Purchase | A | Common Stock | 2,000 | 10.54 | 21.1K | 454,811 | — | ↗ |
| 2021-03-04 | PACE GARY W | Director | P-Purchase | A | Common Stock | 1,500 | 9.27 | 13.9K | 451,811 | — | ↗ |
| 2021-01-02 | Kelemen Vicki | Officer | M-Exempt | A | Common Stock | 70 | 0.00 | — | 5,124 | — | ↗ |
| 2021-01-02 | Erlander Mark | Officer | M-Exempt | A | Common Stock | 260 | 0.00 | — | 13,629 | — | ↗ |
| 2020-11-23 | Kelemen Vicki | Officer | M-Exempt | D | Stock Options | 35,321 | 2.48 | 87.6K | 70,641 | — | ↗ |
| 2020-09-30 | RA CAPITAL MANAGEMENT, L.P. | 10% Owner | — | I | Common Stock | 0 | 0.00 | — | 3,290,000 | — | ↗ |
| 2020-09-16 | PACE GARY W | Director | P-Purchase | A | Common Stock | 1,700 | 5.69 | 9.7K | 449,461 | — | ↗ |
| 2020-06-18 | Kelemen Vicki | Officer | — | D | Common Stock | 0 | 0.00 | — | 5,054 | — | ↗ |
| 2020-06-17 | White Lale | Director | A-Award | A | Stock Options | 28,858 | 2.60 | 75.0K | 40,774 | — | ↗ |
| 2020-06-17 | PACE GARY W | Director | A-Award | A | Stock Options | 28,858 | 2.60 | 75.0K | 40,774 | — | ↗ |
| 2020-06-17 | Markin Rodney S | Director | A-Award | A | Stock Options | 28,858 | 2.60 | 75.0K | 75,827 | — | ↗ |
| 2020-06-17 | JACOB GARY S | Director | A-Award | A | Stock Options | 28,858 | 2.60 | 75.0K | 76,106 | — | ↗ |
| 2020-06-17 | Erlander Mark | Director / Officer | A-Award | A | Stock Options | 221,241 | 2.60 | 575.2K | 380,200 | — | ↗ |
| 2020-06-17 | BRANCACCIO JOHN P | Director | A-Award | A | Stock Options | 28,858 | 2.60 | 75.0K | 76,517 | — | ↗ |
| 2020-06-17 | Armitage James O | Director | A-Award | A | Stock Options | 28,858 | 2.60 | 75.0K | 40,774 | — | ↗ |
| 2020-06-17 | ADAMS THOMAS PHD | Director / Officer | A-Award | A | Stock Options | 173,145 | 2.60 | 450.2K | 477,870 | — | ↗ |
| 2020-05-14 | White Lale | Director | P-Purchase | A | Common Stock | 69,930 | 1.43 | 100.0K | 69,930 | — | ↗ |
| 2020-05-14 | Markin Rodney S | Director | P-Purchase | A | Common Stock | 20,979 | 1.43 | 30.0K | 28,160 | — | ↗ |
| 2020-05-14 | JACOB GARY S | Director | P-Purchase | A | Common Stock | 17,483 | 1.43 | 25.0K | 19,552 | — | ↗ |
| 2020-05-14 | Erlander Mark | Officer | P-Purchase | A | Common Stock | 6,993 | 1.43 | 10.0K | 13,369 | — | ↗ |
| 2020-05-14 | BRANCACCIO JOHN P | Director | P-Purchase | A | Common Stock | 6,993 | 1.43 | 10.0K | 9,260 | — | ↗ |
| 2020-05-14 | Armitage James O | Director | P-Purchase | A | Common Stock | 10,490 | 1.43 | 15.0K | 10,490 | — | ↗ |
| 2020-05-14 | ADAMS THOMAS PHD | Director | P-Purchase | A | Common Stock | 13,986 | 1.43 | 20.0K | 18,875 | — | ↗ |
| 2020-05-11 | PACE GARY W | Director | P-Purchase | A | Common Stock | 447,761 | 1.34 | 600.0K | 447,761 | — | ↗ |
| 2020-04-16 | White Lale | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2020-04-16 | PACE GARY W | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2020-04-16 | Armitage James O | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2020-01-03 | Erlander Mark | Officer | F-InKind | D | Common Stock | 116 | 0.00 | — | 6,376 | — | ↗ |
| 2020-01-02 | Erlander Mark | Officer | M-Exempt | A | Common Stock | 261 | 0.00 | — | 6,492 | — | ↗ |
| 2020-01-01 | Erlander Mark | Officer | M-Exempt | A | Common Stock | 1,250 | 0.00 | — | 6,783 | — | ↗ |
| 2019-10-01 | Erlander Mark | Officer | M-Exempt | A | Common Stock | 1,250 | 0.00 | — | 5,999 | — | ↗ |
| 2019-07-01 | Erlander Mark | Officer | F-InKind | D | Common Stock | 461 | 0.00 | — | 4,749 | — | ↗ |
| 2019-06-20 | Markin Rodney S | Director | A-Award | A | Stock Options | 44,734 | 2.48 | 110.9K | 46,969 | — | ↗ |
| 2019-06-20 | JACOB GARY S | Director | A-Award | A | Stock Options | 44,734 | 2.48 | 110.9K | 48,071 | — | ↗ |
| 2019-06-20 | Erlander Mark | Officer | A-Award | A | Stock Options | 134,203 | 2.48 | 332.8K | 158,959 | — | ↗ |
| 2019-06-20 | Countouriotis Athena | Director | A-Award | A | Stock Options | 44,734 | 2.48 | 110.9K | 46,019 | — | ↗ |
| 2019-06-20 | BRANCACCIO JOHN P | Director | A-Award | A | Stock Options | 44,734 | 2.48 | 110.9K | 47,806 | — | ↗ |
| 2019-06-20 | ADAMS THOMAS PHD | Director / Officer | A-Award | A | Stock Options | 298,230 | 2.48 | 739.6K | 304,725 | — | ↗ |
| 2019-04-01 | Erlander Mark | Officer | M-Exempt | A | Common Stock | 1,250 | 0.00 | — | 4,419 | — | ↗ |
| 2019-01-02 | Erlander Mark | Officer | M-Exempt | A | Common Stock | 1,563 | 0.00 | — | 19,708 | — | ↗ |
| 2019-01-01 | Erlander Mark | Officer | M-Exempt | A | Common Stock | 7,500 | 0.00 | — | 21,180 | — | ↗ |
| 2018-10-01 | Erlander Mark | Officer | M-Exempt | D | Restricted Stock Units | 7,500 | 0.00 | — | 42,188 | — | ↗ |
| 2018-07-24 | Erlander Mark | Officer | A-Award | A | Restricted Stock Units | 45,000 | 0.00 | — | 49,688 | — | ↗ |
| 2018-06-20 | Markin Rodney S | Director | P-Purchase | A | Common Stock | 41,200 | 0.85 | 35.0K | 43,085 | — | ↗ |
| 2018-06-08 | Tennant Stanley | Director | P-Purchase | A | Common Stock | 10,000 | 0.80 | 8.0K | 236,061 | — | ↗ |
| 2018-06-08 | BRANCACCIO JOHN P | Director | P-Purchase | A | Common Stock | 10,000 | 0.80 | 8.0K | 13,598 | — | ↗ |
| 2018-01-30 | WELCH WILLIAM J | Director / Officer | M-Exempt | A | Common Stock | 130,000 | 0.00 | — | 904,655 | — | ↗ |
| 2018-01-30 | Erlander Mark | Officer | M-Exempt | A | Common Stock | 90,000 | 0.00 | — | 147,297 | — | ↗ |
| 2018-01-23 | WELCH WILLIAM J | Director / Officer | A-Award | A | Stock Options | 662,500 | 0.30 | 198.8K | 1,412,500 | — | ↗ |
| 2018-01-23 | Tennant Stanley | Director | A-Award | A | Stock Options | 54,322 | 0.30 | 16.3K | 185,586 | — | ↗ |
| 2018-01-23 | Markin Rodney S | Director | A-Award | A | Stock Options | 54,322 | 0.30 | 16.3K | 160,658 | — | ↗ |
| 2018-01-23 | JACOB GARY S | Director | A-Award | A | Stock Options | 54,322 | 0.30 | 16.3K | 248,101 | — | ↗ |
| 2018-01-23 | Erlander Mark | Officer | A-Award | A | Stock Options | 672,189 | 0.30 | 201.7K | 1,782,189 | — | ↗ |
| 2018-01-23 | Countouriotis Athena | Director | A-Award | A | Stock Options | 54,322 | 0.30 | 16.3K | 92,428 | — | ↗ |
| 2018-01-23 | Billings Paul | Director | A-Award | A | Stock Options | 54,322 | 0.30 | 16.3K | 175,658 | — | ↗ |
| 2018-01-23 | BRANCACCIO JOHN P | Director | A-Award | A | Stock Options | 54,322 | 0.30 | 16.3K | 246,130 | — | ↗ |
| 2018-01-23 | ADAMS THOMAS PHD | Director | A-Award | A | Stock Options | 54,322 | 0.30 | 16.3K | 467,277 | — | ↗ |
| 2018-01-02 | WELCH WILLIAM J | Director / Officer | M-Exempt | A | Common Stock | 50,000 | 0.00 | — | 795,392 | — | ↗ |
| 2018-01-02 | Tennant Stanley | Director | M-Exempt | A | Common Stock | 16,667 | 0.00 | — | 234,545 | — | ↗ |
| 2018-01-02 | Markin Rodney S | Director | M-Exempt | A | Common Stock | 16,667 | 0.00 | — | 22,610 | — | ↗ |
| 2018-01-02 | JACOB GARY S | Director | M-Exempt | D | Restricted Stock Units | 16,667 | 0.00 | — | 0 | — | ↗ |
| 2018-01-02 | Erlander Mark | Officer | M-Exempt | D | Restricted Stock Units | 18,750 | 0.00 | — | 146,250 | — | ↗ |
| 2018-01-02 | Billings Paul | Director | M-Exempt | A | Common Stock | 16,667 | 0.00 | — | 16,667 | — | ↗ |
| 2018-01-02 | BRANCACCIO JOHN P | Director | M-Exempt | A | Common Stock | 16,667 | 0.00 | — | 43,167 | — | ↗ |
| 2018-01-02 | ADAMS THOMAS PHD | Director | M-Exempt | A | Common Stock | 16,667 | 0.00 | — | 351,959 | — | ↗ |
| 2017-10-04 | Tennant Stanley | Director | A-Award | A | Stock Options | 38,106 | 0.72 | 27.4K | 131,264 | — | ↗ |
| 2017-10-04 | Markin Rodney S | Director | A-Award | A | Stock Options | 38,106 | 0.72 | 27.4K | 106,336 | — | ↗ |
| 2017-10-04 | JACOB GARY S | Director | A-Award | A | Stock Options | 38,106 | 0.72 | 27.4K | 193,779 | — | ↗ |
| 2017-10-04 | Billings Paul | Director | A-Award | A | Stock Options | 38,106 | 0.72 | 27.4K | 121,336 | — | ↗ |
| 2017-10-04 | BRANCACCIO JOHN P | Director | A-Award | A | Stock Options | 38,106 | 0.72 | 27.4K | 191,808 | — | ↗ |
| 2017-10-04 | ADAMS THOMAS PHD | Director | A-Award | A | Stock Options | 38,106 | 0.72 | 27.4K | 412,955 | — | ↗ |
| 2017-09-14 | Countouriotis Athena | Director | — | D | Stock Options | 38,106 | 0.72 | 27.4K | 0 | — | ↗ |
| 2017-09-05 | Tennant Stanley | Director | S-Sale | D | Common Stock | 8,334 | 0.69 | 5.8K | 209,394 | — | ↗ |
| 2017-09-02 | Tennant Stanley | Director | M-Exempt | D | Restricted Stock Units | 8,484 | 0.00 | — | 16,667 | — | ↗ |
| 2017-09-02 | Markin Rodney S | Director | M-Exempt | D | Restricted Stock Units | 5,943 | 0.00 | — | 16,667 | — | ↗ |
| 2017-09-02 | JACOB GARY S | Director | M-Exempt | A | Common Stock | 9,287 | 0.00 | — | 132,287 | — | ↗ |
| 2017-09-02 | Erlander Mark | Officer | F-InKind | D | Common Stock | 12,928 | 0.00 | — | 48,051 | — | ↗ |
| 2017-09-02 | Billings Paul | Director | M-Exempt | A | Common Stock | 6,498 | 0.00 | — | 6,498 | — | ↗ |
| 2017-09-02 | BRANCACCIO JOHN P | Director | M-Exempt | D | Restricted Stock Units | 12,667 | 0.00 | — | 16,667 | — | ↗ |
| 2017-09-02 | ADAMS THOMAS PHD | Director | M-Exempt | D | Restricted Stock Units | 8,806 | 0.00 | — | 16,667 | — | ↗ |
| 2017-08-22 | Erlander Mark | Officer | A-Award | A | Stock Options | 385,000 | 0.85 | 327.3K | 1,110,000 | — | ↗ |
| 2017-08-15 | WELCH WILLIAM J | Director / Officer | A-Award | A | Common Stock | 745,392 | 0.00 | — | 745,392 | — | ↗ |
| 2017-04-07 | WELCH WILLIAM J | Director / Officer | A-Award | A | Restricted Stock Units | 130,000 | 0.00 | — | 330,000 | — | ↗ |
| 2017-04-07 | Erlander Mark | Officer | A-Award | A | Restricted Stock Units | 90,000 | 0.00 | — | 195,001 | — | ↗ |
| 2017-01-02 | WELCH WILLIAM J | Director / Officer | A-Award | A | Restricted Stock Units | 200,000 | 0.00 | — | 200,000 | — | ↗ |
| 2017-01-02 | Tennant Stanley | Director | A-Award | A | Restricted Stock Units | 16,667 | 0.00 | — | 16,667 | — | ↗ |
| 2017-01-02 | Markin Rodney S | Director | A-Award | A | Restricted Stock Units | 16,667 | 0.00 | — | 16,667 | — | ↗ |
| 2017-01-02 | JACOB GARY S | Director | A-Award | A | Restricted Stock Units | 16,667 | 0.00 | — | 16,667 | — | ↗ |
| 2017-01-02 | Erlander Mark | Officer | F-InKind | D | Common Stock | 23,968 | 0.00 | — | 31,032 | — | ↗ |
| 2017-01-02 | Billings Paul | Director | A-Award | A | Restricted Stock Units | 16,667 | 0.00 | — | 16,667 | — | ↗ |
| 2017-01-02 | BRANCACCIO JOHN P | Director | A-Award | A | Restricted Stock Units | 16,667 | 0.00 | — | 16,667 | — | ↗ |
| 2017-01-02 | ADAMS THOMAS PHD | Director | A-Award | A | Restricted Stock Units | 16,667 | 0.00 | — | 16,667 | — | ↗ |
| 2016-12-19 | Tennant Stanley | Director | P-Purchase | A | Common Stock | 10,000 | 2.10 | 21.0K | 217,728 | — | ↗ |
| 2016-12-16 | WELCH WILLIAM J | Director / Officer | P-Purchase | A | Common Stock | 2,250 | 2.09 | 4.7K | 4,750 | — | ↗ |
| 2016-12-16 | Tennant Stanley | Director | P-Purchase | A | Common Stock | 14,966 | 2.00 | 29.9K | 207,728 | — | ↗ |
| 2016-12-14 | Erlander Mark | Officer | P-Purchase | A | Common Stock | 5,000 | 2.08 | 10.4K | 5,000 | — | ↗ |
| 2016-11-11 | BRIDGER MANAGEMENT, LLC | — | P-Purchase | D | Common Stock, $.0001 par value per share | 322,472 | 3.08 | 993.2K | 2,968,115 | — | ↗ |
| 2016-05-02 | Erlander Mark | Officer | A-Award | A | Restricted Stock Units | 50,000 | 0.00 | — | 50,000 | — | ↗ |
| 2016-04-25 | WELCH WILLIAM J | Officer | — | D | Stock Options | 750,000 | 4.73 | 3.55M | 0 | — | ↗ |
| 2016-04-21 | ZANIBONI STEVE | Officer | M-Exempt | A | Common Stock | 4,514 | 4.39 | 19.8K | 96,968 | — | ↗ |
| 2016-01-04 | ZANIBONI STEVE | Officer | A-Award | A | Stock Options | 150,000 | 5.18 | 777.0K | 486,637 | — | ↗ |
| 2016-01-04 | Tennant Stanley | Director | A-Award | A | Stock Options | 16,000 | 5.18 | 82.9K | 93,158 | — | ↗ |
| 2016-01-04 | SCHUH ANTONIUS | Director / Officer | A-Award | A | Stock Options | 800,000 | 5.18 | 4.14M | 1,858,333 | — | ↗ |
| 2016-01-04 | Posard Matthew L. | Officer | A-Award | A | Stock Options | 150,000 | 5.18 | 777.0K | 650,000 | — | ↗ |
| 2016-01-04 | Markin Rodney S | Director | A-Award | A | Stock Options | 16,000 | 5.18 | 82.9K | 68,230 | — | ↗ |
| 2016-01-04 | JACOB GARY S | Director | A-Award | A | Stock Options | 16,000 | 5.18 | 82.9K | 155,673 | — | ↗ |
| 2016-01-04 | Erlander Mark | Officer | A-Award | A | Stock Options | 150,000 | 5.18 | 777.0K | 725,000 | — | ↗ |
| 2016-01-04 | Billings Paul | Director | A-Award | A | Stock Options | 16,000 | 5.18 | 82.9K | 83,230 | — | ↗ |
| 2016-01-04 | BRANCACCIO JOHN P | Director | A-Award | A | Stock Options | 16,000 | 5.18 | 82.9K | 153,702 | — | ↗ |
| 2016-01-04 | ADAMS THOMAS PHD | Director | A-Award | A | Stock Options | 16,000 | 5.18 | 82.9K | 374,849 | — | ↗ |
Executive team
Top executives
EBIT / Employee
-14.8K
Shares Outstanding
68.37M
Executive compensation
Executive compensation (annual)
| # | Year | Executive | Salary | Bonus | Stock award | Option award | Incentive | Other | Total | % Stock- based |
Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 2025 | Mark Erlander, CEO | — | — | — | 2.27M | — | — | 2.27M | 100.00% | ↗ |
| 2 | 2025 | Rodger Sidhu, CMO | — | — | — | 1.92M | — | — | 1.92M | 100.00% | ↗ |
| 3 | 2025 | James Levine, CFO | — | — | — | 993.9K | — | — | 993.9K | 100.00% | ↗ |
| 4 | 2024 | Mark Erlander, CEO | — | 319.0K | — | — | — | — | 319.0K | 0.00% | ↗ |
| 5 | 2024 | James Levine, CFO | — | 203.6K | — | — | — | — | 203.6K | 0.00% | ↗ |
| 6 | 2024 | Fairooz Kabbinavar, CMO | — | 186.9K | — | — | — | — | 186.9K | 0.00% | ↗ |
| 7 | 2023 | Mark Erlander, CEO | — | 280.4K | — | — | — | — | 280.4K | 0.00% | ↗ |
| 8 | 2023 | James Levine, CFO | — | 182.8K | — | — | — | — | 182.8K | 0.00% | ↗ |
| 9 | 2023 | Fairooz Kabbinavar, CMO | — | 177.1K | — | — | — | — | 177.1K | 0.00% | ↗ |
| 10 | 2022 | Mark Erlander, CEO | — | 266.5K | — | — | — | — | 266.5K | 0.00% | ↗ |
| 11 | 2022 | James Levine, CFO | — | 168.3K | — | — | — | — | 168.3K | 0.00% | ↗ |
| 12 | 2022 | Tod Smeal, CSO | — | 156.8K | — | — | — | — | 156.8K | 0.00% | ↗ |
| 13 | 2021 | Vicki Kelemen, COO | 360.0K | — | — | 1.32M | 152.3K | — | 1.83M | 72.01% | ↗ |
| 14 | 2021 | Mark Erlander, CEO | — | 250.5K | — | — | — | — | 250.5K | 0.00% | ↗ |
| 15 | 2021 | James Levine, CFO | — | 179.8K | — | — | — | — | 179.8K | 0.00% | ↗ |
| 16 | 2020 | Thomas H. Adams, Executive Chairman | 475.3K | — | — | 372.9K | 227.0K | — | 1.38M | 27.12% | ↗ |
| 17 | 2020 | Mark Erlander, CEO | 444.8K | — | — | 476.4K | 229.6K | — | 1.15M | 41.40% | ↗ |
| 18 | 2020 | Vicki Kelemen, COO | 322.6K | — | — | 269.5K | 157.5K | — | 749.6K | 35.96% | ↗ |
| 19 | 2019 | Thomas H. Adams, Executive Chairman | 491.1K | — | — | 568.9K | 244.6K | — | 1.30M | 43.60% | ↗ |
| 20 | 2019 | Thomas H. Adams, CEO | 491.1K | — | — | 568.9K | 244.6K | — | 1.30M | 43.60% | ↗ |
| 21 | 2019 | Mark Erlander, CEO | 398.7K | — | — | 255.6K | 198.6K | — | 853.0K | 29.97% | ↗ |
| 22 | 2019 | Mark Erlander, CSO | 398.7K | — | — | 255.6K | 198.6K | — | 853.0K | 29.97% | ↗ |
| 23 | 2018 | Mark Erlander, CSO | 387.2K | — | 34.8K | 144.0K | 342.6K | — | 908.5K | 19.68% | ↗ |
| 24 | 2018 | William Welch, former CEO | 630.2K | — | — | 139.4K | — | — | 769.6K | 18.12% | ↗ |
| 25 | 2018 | Thomas H. Adams, CEO | 286.3K | — | — | 11.7K | 79.2K | — | 377.2K | 3.10% | ↗ |
| 26 | 2017 | William Welch, former CEO | 475.0K | — | 1.12M | — | 811.4K | — | 2.41M | 46.62% | ↗ |
| 27 | 2017 | William Welch, CEO | 475.0K | — | 1.12M | — | 811.4K | — | 2.41M | 46.62% | ↗ |
| 28 | 2017 | Dr. Mark Erlander, CSO | 374.4K | — | 296.3K | 225.9K | 125.2K | — | 1.02M | 51.10% | ↗ |
| 29 | 2017 | Mark Erlander, CSO | 374.4K | — | 296.3K | 225.9K | 125.2K | — | 1.02M | 51.10% | ↗ |
| 30 | 2016 | William Welch, CEO | 319.7K | — | — | 3.20M | 115.8K | — | 3.64M | 88.04% | ↗ |
| 31 | 2016 | Dr. Antonius Schuh, Former CEO | 29.6K | — | — | 2.60M | — | — | 2.73M | 95.26% | ↗ |
| 32 | 2016 | Dr. Mark Erlander, CSO | 374.4K | — | 199.5K | 458.2K | 234.0K | — | 1.27M | 51.95% | ↗ |
| 33 | 2016 | Stephen Zaniboni, Former CFO | 94.8K | — | — | 458.2K | — | — | 552.9K | 82.86% | ↗ |
| 34 | 2015 | Matthew Posard, CCO | 256.3K | — | — | 1.82M | 116.2K | — | 2.19M | 83.00% | ↗ |
| 35 | 2015 | Dr. Antonius Schuh, Former CEO | 470.0K | — | — | — | 211.5K | — | 681.5K | 0.00% | ↗ |
| 36 | 2015 | Dr. Mark Erlander, CSO | 372.2K | — | — | — | 162.0K | — | 534.2K | 0.00% | ↗ |
| 37 | 2015 | Stephen Zaniboni, Former CFO | 317.7K | — | — | — | 146.3K | — | 464.0K | 0.00% | ↗ |
| 38 | 2014 | Dr. Mark Erlander, CSO | 298.8K | — | — | 921.4K | 131.2K | — | 1.35M | 68.18% | ↗ |
| 39 | 2014 | Dr. Antonius Schuh, Former CEO | 385.0K | — | — | 400.0K | 154.0K | — | 939.0K | 42.60% | ↗ |
| 40 | 2014 | Stephen Zaniboni, Former CFO | 242.0K | — | — | 263.4K | 96.8K | — | 602.2K | 43.74% | ↗ |
| 41 | 2013 | Dr. Antonius Schuh, Former CEO | 323.1K | — | — | 1.21M | 210.0K | — | 1.75M | 69.47% | ↗ |
| 42 | 2013 | Dr. Mark Erlander, CSO | 169.7K | — | — | 1.37M | 100.0K | — | 1.64M | 83.51% | ↗ |
| 43 | 2013 | Stephen Zaniboni, Former CFO | 201.8K | — | — | 492.7K | 132.0K | — | 826.5K | 59.62% | ↗ |
| 44 | 2005 | V. Randy White, Ph.D, former Chief Executive Officer | 62.0K | — | — | — | — | — | 62.0K | 0.00% | ↗ |
CEO compensation breakdown
Proxy statements
Proxy statements (DEF 14A)
Recent SEC filings
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Tod Smeal | Chief Scientific Officer | 3M | — |
| Josh Muntner | Chief Financial Officer | 674.8K | male |
| Roger Sidhu | Chief Medical Officer | 553.0K | — |
| Mani Mohindru | President, CEO & Director | 77.0K | — |
| Elizabeth Anderson | Vice President of Finance & Administration | — | female |
| Ajay Aggarwal | Chief Operating Officer | — | — |
| Brigitte Lindsay | Chief Accounting Officer | — | female |
ESG Rating
ESG Score History BIOTECHNOLOGY
Benchmark vs Sector
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
No House trading activity found for this company.
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for CRDF
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
